Literature DB >> 29324601

Potentially Preventable Stillbirth in a Diverse U.S. Cohort.

Jessica M Page1, Vanessa Thorsten, Uma M Reddy, Donald J Dudley, Carol J Rowland Hogue, George R Saade, Halit Pinar, Corette B Parker, Deborah Conway, Barbara J Stoll, Donald Coustan, Radek Bukowski, Michael W Varner, Robert L Goldenberg, Karen Gibbins, Robert M Silver.   

Abstract

OBJECTIVE: To estimate the proportion of potentially preventable stillbirths in the United States.
METHODS: We conducted a secondary analysis of 512 stillbirths with complete evaluation enrolled in the Stillbirth Collaborative Research Network from 2006 to 2008. The Stillbirth Collaborative Research Network was a multisite, geographically, racially, and ethnically diverse, population-based case-control study of stillbirth in the United States. Cases of stillbirth underwent standard evaluation that included maternal interview, medical record abstraction, biospecimen collection, postmortem examination, placental pathology, and clinically recommended evaluation. Each stillbirth was assigned probable and possible causes of death using the Initial Causes of Fetal Death algorithm system. For this analysis, we defined potentially preventable stillbirths as those occurring in nonanomalous fetuses, 24 weeks of gestation or greater, and weighing 500 g or greater that were 1) intrapartum, 2) the result of medical complications, 3) the result of placental insufficiency, 4) multiple gestation (excluding twin-twin transfusion), 5) the result of spontaneous preterm birth, or 6) the result of hypertensive disorders of pregnancy.
RESULTS: Of the 512 stillbirths included in our cohort, causes of potentially preventable stillbirth included placental insufficiency (65 [12.7%]), medical complications of pregnancy (31 [6.1%]), hypertensive disorders of pregnancy (20 [3.9%]), preterm labor (16 [3.1%]), intrapartum (nine [1.8%]), and multiple gestations (four [0.8%]). Twenty-seven stillbirths fit two or more categories, leaving 114 (22.3%) potentially preventable stillbirths.
CONCLUSION: Based on our definition, almost one fourth of stillbirths are potentially preventable. Given the predominance of placental insufficiency among stillbirths, identification and management of placental insufficiency may have the most immediate effect on stillbirth reduction.

Entities:  

Mesh:

Year:  2018        PMID: 29324601      PMCID: PMC5785410          DOI: 10.1097/AOG.0000000000002421

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Radek Bukowski appointed Editor of Computational Medicine for AJOG.

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2020-07       Impact factor: 8.661

Review 2.  Investigating Mechanisms of Stillbirth in the Setting of Prenatal Substance Use.

Authors:  Corrie B Miller; Tricia Wright
Journal:  Acad Forensic Pathol       Date:  2018-12-19

3.  Racial and Ethnic Disparities in Fetal Deaths - United States, 2015-2017.

Authors:  Shannon M Pruitt; Donna L Hoyert; Kayla N Anderson; Joyce Martin; Lisa Waddell; Charles Duke; Margaret A Honein; Jennita Reefhuis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-09-18       Impact factor: 17.586

4.  Protocol for the development and validation of a risk prediction model for stillbirths from 35 weeks gestation in Australia.

Authors:  Jessica K Sexton; Michael Coory; Sailesh Kumar; Gordon Smith; Adrienne Gordon; Georgina Chambers; Gavin Pereira; Camille Raynes-Greenow; Lisa Hilder; Philippa Middleton; Anneka Bowman; Scott N Lieske; Kara Warrilow; Jonathan Morris; David Ellwood; Vicki Flenady
Journal:  Diagn Progn Res       Date:  2020-12-16

5.  Decoding stillbirths using the Relevant Condition at Death classification: Study from the developing world

Authors:  Neeraj Kulkarni; Deepti Pinto Rosario; Liji Sarah David; Reeta Vijayaselvi; Manisha Madhai Beck
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-10-26

6.  Stillbirths in China: a nationwide survey.

Authors:  J Zhu; J Zhang; H Xia; J Ge; X Ye; B Guo; M Liu; L Dai; L Zhang; L Chen; Y Wang; X Wang; H Liu; C Chen; Y Wang; G Wang; M Cai; X Yang; F Li; C Fan; Y Ruan; L Yu; R Zhang; H Xu; J Zhang; X Ma; D Yuan; Y Zhu; D Wang; A P Betran; H Qi; T Duan; J Zhang
Journal:  BJOG       Date:  2020-09-02       Impact factor: 6.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.